Stock 603590 BEIJING KONRUNS PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing Konruns Pharmaceutical Co.,Ltd.

Equities

603590

CNE1000036K3

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 06/05/2024 am IST 		5-day change 1st Jan Change
31.25 CNY +5.65% Intraday chart for Beijing Konruns Pharmaceutical Co.,Ltd. +6.00% -17.94%
25/04 Beijing Konruns Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
08/04 Beijing Konruns Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Beijing Konruns Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of drugs. The Company's main product Suling belongs to the haemocoagulase drug that activates the coagulation process, which is mainly used for hemostasis of superficial wound bleeding in surgical operations as well as the bleeding caused by postoperative, trauma and disease. The Company’s present products under research include a range of innovative and generic drugs for tumors and blood. The Company mainly distributes its products in the domestic market.

Number of employees: 449

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
867 100.0 % 920 100.0 % +6.15%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.1 %
856 98.8 % 912 99.1 % +6.52%
Overseas
0.9 %
11 1.2 % 8 0.9 % -24.36%

Managers

Managers TitleAgeSince
Jian Hua Liu FOU
 Founder 64 03/03/03
Xi Juan Wang FOU
 Founder 63 03/03/03
Zhan Qi Niu PSD
 President 57 20/23/20
Yu Ping Sun DFI
 Director of Finance/CFO 51 25/21/25
Ling Wang BRD
 Director/Board Member 51 -
Shi Na Zhang IRC
 Investor Relations Contact 40 01/21/01

Members of the board

Members of the board TitleAgeSince
Xi Juan Wang FOU
 Founder 63 03/03/03
Li Jia Fu BRD
 Director/Board Member 61 27/21/27
Jian Hua Liu FOU
 Founder 64 03/03/03
Xiao Han Liu BRD
 Director/Board Member 37 01/11/01
Fang Fang BRD
 Director/Board Member 45 02/11/02
Ling Wang BRD
 Director/Board Member 51 -
Jin Li BRD
 Director/Board Member 59 13/23/13
Yong Gong Zhai BRD
 Director/Board Member 63 27/21/27
Yong Xin Han BRD
 Director/Board Member - 13/22/13
Hong Yi Li BRD
 Director/Board Member 51 13/22/13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 160,000,000 73,054,459 ( 45.66 %) 3,508,623 ( 2.193 %) 45.66 %

Shareholders

NameEquities%Valuation
Jian Hua Liu
37.74 %
60,386,760 37.74 % 262 M ¥
Xi Juan Wang
10.15 %
16,245,600 10.15 % 70 M ¥
Citic Securities Co., Ltd. (Invt Port)
1.772 %
2,835,400 1.772 % 12 M ¥
China Southern Asset Management Co., Ltd.
0.9698 %
1,551,730 0.9698 % 7 M ¥
Hwabao WP Fund Management Co., Ltd.
0.7929 %
1,268,600 0.7929 % 5 M ¥
Penghua Fund Management Co., Ltd.
0.6499 %
1,039,800 0.6499 % 5 M ¥
Fullgoal Fund Management Co., Ltd.
0.3246 %
519,300 0.3246 % 2 M ¥
HFT Investment Management Co., Ltd.
0.3185 %
509,548 0.3185 % 2 M ¥
HuaAn Fund Management Co., Ltd.
0.1868 %
298,900 0.1868 % 1 M ¥
Nuode Asset Management Co., Ltd.
0.1815 %
290,418 0.1815 % 1 M ¥

Holdings

NameEquities%Valuation
CHINA NATIONAL MEDICINES CORPORATION LTD.
1.85%
 10,236,189 1.85% 46,737,722 $

Company contact information

Beijing Konruns Pharmaceutical Co., Ltd.

Bldg 3, 7, Science Park Road Zhongguancun Life Science Park

102206, Beijing

+

http://www.konruns.cn
address Beijing Konruns Pharmaceutical Co.,Ltd.(603590)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Beijing Konruns Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
31.25 CNY
Average target price
44 CNY
Spread / Average Target
+40.80%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BEIJING KONRUNS PHARMACEUTICAL CO.,LTD. Stock Beijing Konruns Pharmaceutical Co.,Ltd.
-17.94% 640M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.52% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.96% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.21% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.02% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.01% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.81% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.63% 194B
AMGEN INC. Stock Amgen Inc.
+3.98% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603590 Stock
  4. Company Beijing Konruns Pharmaceutical Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW